ADR Biomedical HoldingsADR Biomedical Holdings Inc.3750東証スタンダード情報・通信業FY ending Mar 2026, consolidated, J-GAAP

ADR Biomedical Holdings FY ending Mar 2026 results

ADR Biomedical Holdings brought in ¥51M in revenue.

It lost about ¥1777 for every ¥100 of sales at the operating level.

Revenue changed -58.3% from the prior year.

What changed from last year

FY ending Mar 2025 → FY ending Mar 2026

Revenue
-58.3%¥122.2M → ¥51M
Gross profit
Back to profit-¥6M → ¥10.6M
Operating income
Loss-¥806.9M → -¥906.2M
Net income attributable to owners
Loss-¥2.14B → -¥396.9M
Operating cash flow
Loss-¥987M → -¥784.8M

Where the money goes

FY ending Mar 2025 → FY ending Mar 2026

Where ¥100 of sales goes

For every ¥100 ADR Biomedical Holdings sells, how much goes where, and how much is kept.

FY ending Mar 2026
Cost of sales
¥79
SG&A
¥1798
Operating loss
¥1777
Net loss
¥778

Annual margin trends

Gross margin20.7%
FY ending Mar 2021: 54.8%54.8%FY ending Mar 2022: 64.3%64.3%FY ending Mar 2023: 59.2%59.2%FY ending Mar 2024: 82.8%82.8%FY ending Mar 2025: -4.9%-4.9%FY ending Mar 2026: 20.7%20.7%FY21FY22FY23FY24FY25FY26
Operating margin-1777.2%
FY ending Mar 2021: -52.7%-52.7%FY ending Mar 2022: -34.6%-34.6%FY ending Mar 2023: -37.0%-37.0%FY ending Mar 2024: -49.5%-49.5%FY ending Mar 2025: -660.3%-660.3%FY ending Mar 2026: -1777.2%-1777.2%FY21FY22FY23FY24FY25FY26
Net margin-778.4%
FY ending Mar 2021: -59.9%-59.9%FY ending Mar 2022: -5.8%-5.8%FY ending Mar 2023: -49.4%-49.4%FY ending Mar 2024: 8.9%8.9%FY ending Mar 2025: -1751.2%-1751.2%FY ending Mar 2026: -778.4%-778.4%FY21FY22FY23FY24FY25FY26

Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.

Sources

Show source documents (6)
  • EDINET (FSA Japan)

    有価証券報告書-第22期(2025/04/01-2026/03/31)

    ID S100YLDW2026-06-26Open
  • EDINET (FSA Japan)

    訂正有価証券報告書-第21期(2024/04/01-2025/03/31)

    ID S100WZTN2025-11-07Open
  • EDINET (FSA Japan)

    有価証券報告書-第20期(2023/04/01-2024/03/31)

    ID S100TUF62024-06-26Open
  • EDINET (FSA Japan)

    訂正有価証券報告書-第19期(2022/04/01-2023/03/31)

    ID S100RS4G2023-08-30Open
  • EDINET (FSA Japan)

    有価証券報告書-第18期(令和3年4月1日-令和4年3月31日)

    ID S100OEC72022-06-23Open
  • EDINET (FSA Japan)

    有価証券報告書-第17期(令和2年4月1日-令和3年3月31日)

    ID S100LPPV2021-06-24Open

Extracted from XBRL: 42

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.